DN
Laurus Labs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ARV Portfolio (e.g., Dolutegravir, Tenofovir) | HIV/AIDS | Commercial |
| Oncology APIs (e.g., Sorafenib, Lenalidomide) | Various Cancers | Commercial/Filed |
| Cardiovascular APIs (e.g., Valsartan, Atorvastatin) | Hypertension, High Cholesterol | Commercial |
| Biosimilars Pipeline | Oncology, Autoimmune Diseases | Development |
| CDMO Projects | Client-specific | Development to Commercial |
Leadership Team at Laurus Labs
DS
Dr. Satyanarayana Chava
Founder & Chief Executive Officer
VV
V. V. Ravi Kumar
Executive Director & Chief Financial Officer
DR
Dr. Rajendra Prasad
Chief Operating Officer (API Business)
CV
Chava Venkata Satyanarayana Reddy
Whole-time Director
DM
Dr. M. M. Murthy
Senior Vice President, Research & Development
SR
S. R. Rao
Independent Director
DB
Dr. B. N. Suresh
Independent Director
MS
M. S. Ramachandran
Independent Director
D(
Dr. (Mrs.) Nirmaljeet Kaur
Independent Director
SK
Sanjay K. Jain
Company Secretary & Compliance Officer